200 related articles for article (PubMed ID: 8873894)
1. Regulation of VIP gene expression in general. Human lung cancer cells in particular.
Davidson A; Moody TW; Gozes I
J Mol Neurosci; 1996; 7(2):99-110. PubMed ID: 8873894
[TBL] [Abstract][Full Text] [Related]
2. A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.
Moody TW; Zia F; Draoui M; Brenneman DE; Fridkin M; Davidson A; Gozes I
Proc Natl Acad Sci U S A; 1993 May; 90(10):4345-9. PubMed ID: 8389448
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells.
Casibang M; Purdom S; Jakowlew S; Neckers L; Zia F; Ben-Av P; Hla T; You L; Jablons DM; Moody TW
Lung Cancer; 2001; 31(2-3):203-12. PubMed ID: 11165399
[TBL] [Abstract][Full Text] [Related]
4. Effects of transforming growth factor-beta 1 and phorbol ester on PAI-1 and PA genes in human lung cells.
Jakowlew SB; Mariano JM; You L
Growth Factors; 1997; 14(2-3):177-97. PubMed ID: 9255608
[TBL] [Abstract][Full Text] [Related]
5. Identification of early growth response gene-1 (Egr-1) as a phorbol myristate acetate-induced gene in lung cancer cells by differential mRNA display.
You L; Jakowlew SB
Am J Respir Cell Mol Biol; 1997 Nov; 17(5):617-24. PubMed ID: 9374113
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific expression of the vasoactive intestinal peptide gene requires both an upstream tissue specifier element and the 5' proximal cyclic AMP-responsive element.
Hahm SH; Eiden LE
J Neurochem; 1996 Nov; 67(5):1872-81. PubMed ID: 8863492
[TBL] [Abstract][Full Text] [Related]
7. Phorbol esters regulate preprogastrin-releasing peptide messenger RNA in small cell lung cancer cells.
Draoui M; Moody TW; Fathi Z; Battey J
Cell Growth Differ; 1993 Sep; 4(9):723-9. PubMed ID: 8241020
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide gene expression in the rat pheochromocytoma cell line PC12.
Tsukada T; Fukushima M; Takebe H; Nakai Y
Mol Cell Endocrinol; 1995 Feb; 107(2):231-9. PubMed ID: 7768335
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal polypeptide binds with high affinity to non-small cell lung cancer cells and elevates cyclic AMP levels.
Lee M; Jensen RT; Huang SC; Bepler G; Korman L; Moody TW
Peptides; 1990; 11(6):1205-9. PubMed ID: 1965032
[TBL] [Abstract][Full Text] [Related]
10. Distinct regulation of vasoactive intestinal peptide (VIP) expression at mRNA and peptide levels in human neuroblastoma cells.
Agoston DV; Colburn S; Krajniak KG; Waschek JA
Neurosci Lett; 1992 May; 139(2):213-6. PubMed ID: 1319016
[TBL] [Abstract][Full Text] [Related]
11. (Stearyl, Norleucine17)VIP hybrid antagonizes VIP receptors on non-small cell lung cancer cells.
Moody TW; Leyton J; Coelho T; Jakowlew S; Takahashi K; Jameison F; Koh M; Fridkin M; Gozes I; Knight M
Life Sci; 1997; 61(17):1657-66. PubMed ID: 9363981
[TBL] [Abstract][Full Text] [Related]
12. Differential induction of early response genes by adrenomedullin and transforming growth factor-beta1 in human lung cancer cells.
Kane S; Prentice MA; Mariano JM; Cuttitta F; Jakowlew SB
Anticancer Res; 2002; 22(3):1433-44. PubMed ID: 12168820
[TBL] [Abstract][Full Text] [Related]
13. See-saw signal processing: reciprocal effects of stimulus deprivation on vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate accumulation in rat pinealocytes.
Chik CL; Ho AK
Endocrinology; 1991 Feb; 128(2):850-6. PubMed ID: 1846590
[TBL] [Abstract][Full Text] [Related]
14. Effects of vasoactive intestinal peptide on adenosine 3',5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.
Yu D; Seitz PK; Selvanayagam P; Rajaraman S; Townsend CM; Cooper CW
Endocrinology; 1992 Sep; 131(3):1188-94. PubMed ID: 1324153
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal polypeptide inhibits c-myc expression and growth of human gastric carcinoma cells.
Kim SW; Beauchamp RD; Townsend CM; Thompson JC
Surgery; 1991 Aug; 110(2):270-5; discussion 276. PubMed ID: 1713357
[TBL] [Abstract][Full Text] [Related]
16. The regulation of prodynorphin gene expression in cultured spinal cord cells: involvement of second messengers.
Ha TS; Kim YH; Song DK; Wie MB; Suh HW
Neuropeptides; 1997 Apr; 31(2):125-30. PubMed ID: 9179864
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP- and phorbol ester-induced transcriptional activation are mediated by the same enhancer element in the human vasoactive intestinal peptide gene.
Fink JS; Verhave M; Walton K; Mandel G; Goodman RH
J Biol Chem; 1991 Feb; 266(6):3882-7. PubMed ID: 1847391
[TBL] [Abstract][Full Text] [Related]
19. Lineage-specific regulation of the vasoactive intestinal peptide gene in neuroblastoma cells is conferred by 5.2 kilobases of 5'-flanking sequence.
Waschek JA; Hsu CM; Eiden LE
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9547-51. PubMed ID: 3200839
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 alpha and tumor necrosis factor-alpha differentially regulate enkephalin, vasoactive intestinal polypeptide, neurotensin, and substance P biosynthesis in chromaffin cells.
Eskay RL; Eiden LE
Endocrinology; 1992 Apr; 130(4):2252-8. PubMed ID: 1372239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]